ACET FY 2009 Earnings — Adicet Bio, Inc. Revenue & Financial Results | Market Cap Arena

ACETAdicet Bio, Inc.

$68M

FY 2009 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$323M-10.3% YoY

Gross Profit

$56M17.2% margin

Operating Income

$12M3.7% margin

Net Income

$9M2.7% margin

EPS (Diluted)

$6.24

Cash Flow

Operating Cash Flow

$23M

Free Cash Flow

$22M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$189M

Total Liabilities

$64M

Stockholders' Equity

$142M

Cash & Equivalents

$58M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$323M	$360M	-10.3%
Gross Profit	$56M	$67M	-17.4%
Operating Income	$12M	$21M	-44.4%
Net Income	$9M	$13M	-36.0%